NYSE - Delayed Quote USD
Ginkgo Bioworks Holdings, Inc. (DNA)
Tune into live earnings calls Now streaming directly on quote pages.
7.04
+0.08
+(1.15%)
At close: May 2 at 4:00:02 PM EDT
7.16
+0.12
+(1.70%)
After hours: May 2 at 7:55:11 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 4 | 6 | 5 |
| Avg. Estimate | 38.7M | 43.74M | 173.04M | 201.9M |
| Low Estimate | 37M | 41.8M | 169.7M | 178.74M |
| High Estimate | 40.5M | 45.5M | 179M | 250M |
| Year Ago Sales | 37.94M | 56.21M | 227.04M | 173.04M |
| Sales Growth (year/est) | 1.98% | -22.17% | -23.79% | 16.68% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -3.2 | -3.12 | -3.32 | -1.3 |
| EPS Actual | -2.87 | -4.4 | -1.08 | -1.21 |
| Difference | 0.33 | -1.28 | 2.24 | 0.09 |
| Surprise % | 10.38% | -41.03% | 67.49% | 6.65% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DNA | -- | -- | -- | -- |
| S&P 500 | 12.40% | 3.81% | 8.28% | 13.79% |
Upgrades & Downgrades
| Maintains | TD Cowen: Buy to Buy | 9/20/2024 |
| Maintains | BTIG: Sell to Sell | 8/23/2024 |
| Maintains | Goldman Sachs: Sell to Sell | 7/9/2024 |
| Maintains | BTIG: Sell to Sell | 6/26/2024 |
| Downgrade | BTIG: Neutral to Sell | 5/15/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 5/15/2024 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
8.84
+2.31%
RXRX Recursion Pharmaceuticals, Inc.
5.70
+3.64%
BEAM Beam Therapeutics Inc.
20.24
+2.07%
EDIT Editas Medicine, Inc.
1.6400
+1.23%
CRSP CRISPR Therapeutics AG
38.25
+1.38%
VERV Verve Therapeutics, Inc.
5.19
-5.64%
ABCL AbCellera Biologics Inc.
2.4100
-3.21%
IOVA Iovance Biotherapeutics, Inc.
3.5000
+5.11%
CRBU Caribou Biosciences, Inc.
0.8800
+9.75%
SMMT Summit Therapeutics Inc.
27.90
+13.09%